Larvol Delta - Acumen-Pharmaceuticals-Presents-Positive-Topline-Results-from-FirstinHuman-Phase-1-Study-of-ACU193-for-Early-Alzheimers-Disease-at-the-Alzheimers-Association-International-Conference-AAIC-2023

ACU193 - Acumen Pharma

https://www.globenewswire.com/news-release/2023/07/16/2705282/0/en/Acumen-Pharmaceuticals-Presents-Positive-Topline-Results-from-First-in-Human-Phase-1-Study-of-ACU193-for-Early-Alzheimer-s-Disease-at-the-Alzheimer-s-Association-International-Conf.html

Jul 16, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next